Franklin D. Lowy: Oxazolidinones. W: Jonathan Cohen, William G. Powderly, Steven M. Opal: Infectious Diseases. T. 2. Elsevier, 2017, s. 1230-1232.e1. DOI: 10.1016/C2013-1-00044-3. ISBN 978-0-7020-6285-8.
A. Kali, MV. Charles, S. Srirangaraj. Cadazolid: A new hope in the treatment of Clostridium difficile infection.. „Australas Med J”. 8 (8), s. 253-62, 2015. DOI: 10.4066/AMJ.2015.2441. PMID: 26392822.
I. Karpiuk, S. Tyski. Looking for the new preparations for antibacterial therapy. V. New antimicrobial agents from the oxazolidinones groups in clinical trials. „Przegl Epidemiol”. 71 (2), s. 207-219, 2017. PMID: 28872286.
A. Kali, MV. Charles, S. Srirangaraj. Cadazolid: A new hope in the treatment of Clostridium difficile infection.. „Australas Med J”. 8 (8), s. 253-62, 2015. DOI: 10.4066/AMJ.2015.2441. PMID: 26392822.